Mechanisms involved in the association between peridontal diseases and cardiovascular disease

Oral Diseases

Volumn 17, Issue 5, 2011, Pages 450-461

  Teles, R ^a,b   Wang, C Y ^c  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Atherosclerosis; Bacteremia; C reactive protein; Cardiovascular disease; Infection; Inflammatory response; Periodontal diseases; Periodontal pathogens; Systemic biomarkers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; METALLOPROTEINASE; TOLL LIKE RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL INVASION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MOUTH FLORA; MOUTH INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGEN LOAD; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW;

ATHEROSCLEROSIS; BACTERIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PERIODONTAL DISEASES;

EID: 79957969674     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01784.x     Document Type: Review

References (136)

1. Abranches J, Zeng L, Belanger M et al (2009). Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol Immunol 24: 141-145.
2. Aimetti M, Romano F, Nessi F (2007). Microbiologic analysis of periodontal pockets and carotid atheromatous plaques in advanced chronic periodontitis patients. J Periodontol 78: 1718-1723.
3. Ajwani S, Mattila KJ, Tilvis RS, Ainamo A (2003). Periodontal disease and mortality in an aged population. Spec Care Dentist 23: 125-130.
4. Amar S, Wu SC, Madan M (2009). Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J Immunol 182: 1584-1592.
5. Amorino GP, Hoover RL (1998). Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol 152: 199-207.
6. Andraws R, Berger JS, Brown DL (2005). Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293: 2641-2647.
7. Aukhil I, Lopatin DE, Syed SA, Morrison EC, Kowalski CJ (1988). The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms. J Clin Periodontol 15: 544-550.
8. Baddour LM, Wilson WR, Bayer AS et al (2005). Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111: e394-e434.
9. Beck JD, Offenbacher S (2002). Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol 7: 79-89.
10. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996). Periodontal disease and cardiovascular disease. J Periodontol 67: 1123-1137.
11. Beck JD, Eke P, Heiss G et al (2005a). Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 112: 19-24.
12. Beck JD, Eke P, Lin D et al (2005b). Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183: 342-348.
13. Beck JD, Couper DJ, Falkner KL et al (2008). The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol 79: 90-96.
14. Behle JH, Sedaghatfar MH, Demmer RT et al (2009). Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 36: 287-294.
15. Bengtsson T, Karlsson H, Gunnarsson P et al (2008). The periodontal pathogen Porphyromonas gingivalis cleaves apoB-100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation. J Intern Med 263: 558-571.
16. Blum A, Front E, Peleg A (2007). Periodontal care may improve systemic inflammation. Clin Invest Med 30: E114-E117.
17. Boring L, Gosling J, Cleary M, Charo IF (1998). Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897.
18. Buhlin K, Hultin M, Norderyd O et al (2009). Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 36: 541-549.
19. Cavrini F, Sambri V, Moter A et al (2005). Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol 54: 93-96.
20. Chou HH, Yumoto H, Davey M et al (2005). Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun 73: 5367-5378.
21. Clinton SK, Libby P (1992). Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 116: 1292-1300.
22. Crasta K, Daly CG, Mitchell D, Curtis B, Stewart D, Heitz-Mayfield LJ (2009). Bacteraemia due to dental flossing. J Clin Periodontol 36: 323-332.
23. D'Aiuto F, Ready D, Tonetti MS (2004). Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 39: 236-241.
24. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS (2005). C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179: 413-417.
25. Deshpande RG, Khan M, Genco CA (1998). Invasion strategies of the oral pathogen porphyromonas gingivalis: implications for cardiovascular disease. Invasion Metastasis 18: 57-69.
26. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM (1993). Dental disease and risk of coronary heart disease and mortality. BMJ 306: 688-691.
27. Desvarieux M, Demmer RT, Rundek T et al (2005). Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582.
28. Ding Y, Uitto VJ, Firth J et al (1995). Modulation of host matrix metalloproteinases by bacterial virulence factors relevant in human periodontal diseases. Oral Dis 1: 279-286.
29. Dorn BR, Dunn WA Jr, Progulske-Fox A (1999). Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 67: 5792-5798.
30. Ebersole JL, Cappelli D, Steffen MJ (1992). Characteristics and utilization of antibody measurements in clinical studies of periodontal disease. J Periodontol 63: 1110-1116.
31. Elkaim R, Dahan M, Kocgozlu L et al (2008). Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. J Periodontal Res 43: 224-231.
32. Elkind MS (2010). Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect Disord Drug Targets 10: 84-90.
33. Epstein SE, Zhu J, Najafi AH, Burnett MS (2009). Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119: 3133-3141.
34. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV (2005). Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 76: 731-736.
35. Fietta P, Delsante G (2009). Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"? Acta Biomed 80: 177-186.
36. Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G (2005a). Characterization of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol 12: 259-267.
37. Ford PJ, Gemmell E, Hamlet SM et al (2005b). Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol 20: 296-302.
38. Ford PJ, Gemmell E, Chan A et al (2006). Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 21: 206-211.
39. Forner L, Larsen T, Kilian M, Holmstrup P (2006a). Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 33: 401-407.
40. Forner L, Nielsen CH, Bendtzen K, Larsen T, Holmstrup P (2006b). Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. J Clin Periodontol 33: 724-729.
41. Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ (2009). Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 58: 1568-1575.
42. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000). Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71: 1535-1545.
43. Gamonal J, Sanz M, O'Connor A et al (2003). Delayed neutrophil apoptosis in chronic periodontitis patients. J Clin Periodontol 30: 616-623.
44. Gani DK, Lakshmi D, Krishnan R, Emmadi P (2009). Evaluation of C-reactive protein and interleukin-6 in the peripheral blood of patients with chronic periodontitis. J Indian Soc Periodontol 13: 69-74.
45. Gleissner C, Willershausen B, Kaesser U, Bolten WW (1998). The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res 3: 387-392.
46. Gorska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K (2003). Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 30: 1046-1052.
47. Haffajee AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontol 2000: 78-111.
48. Hajishengallis G, Sharma A, Russell MW, Genco RJ (2002). Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis. Ann Periodontol 7: 72-78.
49. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ (2000). Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 1554-1560.
50. Honda T, Oda T, Yoshie H, Yamazaki K (2005). Effects of Porphyromonas gingivalis antigens and proinflammatory cytokines on human coronary artery endothelial cells. Oral Microbiol Immunol 20: 82-88.
51. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF (2003). Interleukin-1beta, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 38: 247-254.
52. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG (2001). Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 37: 445-450.
53. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA (2000). Periodontal disease and coronary heart disease risk. JAMA 284: 1406-1410.
54. Hujoel PP, White BA, Garcia RI, Listgarten MA (2001). The dentogingival epithelial surface area revisited. J Periodontal Res 36: 48-55.
55. Hulthe J, Fagerberg B (2002). Circulating oxidized LDL is associated with increased levels of cell-adhesion molecules in clinically healthy 58-year old men (AIR study). Med Sci Monit 8: CR148-CR152.
56. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M (2008). Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 23: 2079-2086.
57. Hung HC, Joshipura KJ, Colditz G et al (2004). The association between tooth loss and coronary heart disease in men and women. J Public Health Dent 64: 209-215.
58. Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, Wilson RF (2004). The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 75: 420-428.
59. Janket SJ, Baird AE, Chuang SK, Jones JA (2003). Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 559-569.
60. Johansson A, Buhlin K, Koski R, Gustafsson A (2005). The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis. Eur J Oral Sci 113: 197-202.
61. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC (1996). Poor oral health and coronary heart disease. J Dent Res 75: 1631-1636.
62. Kang IC, Kuramitsu HK (2002). Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol 34: 311-317.
63. Kasser UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW (1997). Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 40: 2248-2251.
64. Khlgatian M, Nassar H, Chou HH, Gibson FC III, Genco CA (2002). Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70: 257-267.
65. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A (2005). Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 25: e17-e18.
66. Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D (2006). Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect 8: 687-693.
67. Kuramitsu HK, Qi M, Kang IC, Chen W (2001). Role for periodontal bacteria in cardiovascular diseases. Ann Periodontol 6: 41-47.
68. Kweider M, Lowe GD, Murray GD, Kinane DF, McGowan DA (1993). Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J 38: 73-74.
69. Lester SR, Bain JL, Serio FG, Harrelson BD, Johnson RB (2009). Relationship between gingival angiopoietin-1 concentrations and depth of the adjacent gingival sulcus. J Periodontol 80: 1447-1453.
70. Li D, Liu L, Chen H, Sawamura T, Mehta JL (2003). LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23: 816-821.
71. Li L, Michel R, Cohen J, Decarlo A, Kozarov E (2008). Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiol 8: 26.
72. Libby P (2002). Inflammation in atherosclerosis. Nature 420: 868-874.
73. Libby P, Theroux P (2005). Pathophysiology of coronary artery disease. Circulation 111: 3481-3488.
74. Lockhart PB, Brennan MT, Thornhill M et al (2009). Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 140: 1238-1244.
75. Loos BG (2005). Systemic markers of inflammation in periodontitis. J Periodontol 76: 2106-2115.
76. Lopez NJ, Quintero A, Llancaqueo M, Jara L (2009). [Effects of periodontal therapy on markers of systemic inflammation in patients with coronary heart disease risk]. Rev Med Chil 137: 1315-1322.
77. Lucas V, Roberts GJ (2000). Odontogenic bacteremia following tooth cleaning procedures in children. Pediatr Dent 22: 96-100.
78. Mahendra J, Mahendra L, Kurian VM, Jaishankar K, Mythilli R (2010). 16S rRNA-based detection of oral pathogens in coronary atherosclerotic plaque. Indian J Dent Res 21: 248-252.
79. Marcaccini AM, Novaes AB Jr, Meschiari CA et al (2009). Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta 409: 117-122.
80. Mason DP, Kenagy RD, Hasenstab D et al (1999). Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85: 1179-1185.
81. Mattila KJ, Nieminen MS, Valtonen VV et al (1989). Association between dental health and acute myocardial infarction. BMJ 298: 779-781.
82. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK (1995). Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 20: 588-592.
83. Mattila KJ, Pussinen PJ, Paju S (2005). Dental infections and cardiovascular diseases: a review. J Periodontol 76: 2085-2088.
84. Mengel R, Bacher M, Flores-De-Jacoby L (2002). Interactions between stress, interleukin-1beta, interleukin-6 and cortisol in periodontally diseased patients. J Clin Periodontol 29: 1012-1022.
85. Mercado FB, Marshall RI, Klestov AC, Bartold PM (2001). Relationship between rheumatoid arthritis and periodontitis. J Periodontol 72: 779-787.
86. Meyle J (1993). Neutrophil chemotaxis and serum concentration of tumor-necrosis-factor-alpha (TNFA). J Periodontal Res 28: 491-493.
87. Morrison HI, Ellison LF, Taylor GW (1999). Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 6: 7-11.
88. Mustapha IZ, Debrey S, Oladubu M, Ugarte R (2007). Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 78: 2289-2302.
89. Nakajima T, Honda T, Domon H et al (2010). Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 45: 116-122.
90. Nakamura N, Yoshida M, Umeda M et al (2008). Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196: 59-67.
91. Nakano K, Inaba H, Nomura R et al (2006). Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol 44: 3313-3317.
92. Nassar H, Chou HH, Khlgatian M, Gibson FC III, Van Dyke TE, Genco CA (2002). Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70: 268-276.
93. Nonnenmacher C, Stelzel M, Susin C et al (2007). Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol 78: 1724-1730.
94. Offenbacher S, Beck JD, Moss K et al (2009). Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 80: 190-201.
95. Packard RR, Libby P (2008). Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38.
96. Papapanou PN, Neiderud AM, Disick E, Lalla E, Miller GC, Dahlen G (2004). Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol 31: 985-990.
97. Paraskevas S, Huizinga JD, Loos BG (2008). A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35: 277-290.
98. Pearson TA, Mensah GA, Alexander RW et al (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
99. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984). Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27: 864-872.
100. Pucar A, Milasin J, Lekovic V et al (2007). Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J Periodontol 78: 677-682.
101. Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V (2003). Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol 23: 1250-1254.
102. Pussinen PJ, Alfthan G, Tuomilehto J, Asikainen S, Jousilahti P (2004). High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur J Cardiovasc Prev Rehabil 11: 408-411.
103. Pussinen PJ, Nyyssonen K, Alfthan G, Salonen R, Laukkanen JA, Salonen JT (2005). Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 25: 833-838.
104. Pussinen PJ, Alfthan G, Jousilahti P, Paju S, Tuomilehto J (2007). Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 193: 222-228.
105. Qi M, Miyakawa H, Kuramitsu HK (2003). Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 35: 259-267.
106. Rahman AU, Rashid S, Noon R et al (2005). Prospective evaluation of the systemic inflammatory marker C-reactive protein in patients with end-stage periodontitis getting teeth replaced with dental implants: a pilot investigation. Clin Oral Implants Res 16: 128-131.
107. Renvert S, Pettersson T, Ohlsson O, Persson GR (2006). Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J Periodontol 77: 1110-1119.
108. Ridker PM, Danielson E, Fonseca FA et al (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207.
109. Roberts FA, Hockett RD Jr, Bucy RP, Michalek SM (1997a). Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiol Immunol 12: 336-344.
110. Roberts FA, McCaffery KA, Michalek SM (1997b). Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 76: 1833-1839.
111. Robertson AK, Hansson GK (2006). T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 26: 2421-2432.
112. Roth GA, Moser B, Huang SJ et al (2006). Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost 4: 2256-2261.
113. Rupprecht HJ, Blankenberg S, Bickel C et al (2001). Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104: 25-31.
114. Saito Y, Fujii R, Nakagawa KI, Kuramitsu HK, Okuda K, Ishihara K (2008). Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis. Oral Microbiol Immunol 23: 1-6.
115. Sakellari D, Socransky SS, Dibart S, Eftimiadi C, Taubman MA (1997). Estimation of serum antibody to subgingival species using checkerboard immunoblotting. Oral Microbiol Immunol 12: 303-310.
116. Sattar N, McCarey DW, Capell H, McInnes IB (2003). Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108: 2957-2963.
117. Sheets SM, Potempa J, Travis J, Casiano CA, Fletcher HM (2005). Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun 73: 1543-1552.
118. Spahr A, Klein E, Khuseyinova N et al (2006). Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 166: 554-559.
119. Stinson MW, Alder S, Kumar S (2003). Invasion and killing of human endothelial cells by viridans group streptococci. Infect Immun 71: 2365-2372.
120. Takahashi Y, Davey M, Yumoto H, Gibson FC III, Genco CA (2006). Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell Microbiol 8: 738-757.
121. Taylor BA, Tofler GH, Carey HM et al (2006). Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res 85: 74-78.
122. Teles R, Sakellari D, Teles F et al (2010a). Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. J Periodontol 81: 89-98.
123. Teles RP, Gursky LC, Faveri M et al (2010b). Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol 37: 313-323.
124. Tomas I, Alvarez M, Limeres J, Potel C, Medina J, Diz P (2007). Prevalence, duration and aetiology of bacteraemia following dental extractions. Oral Dis 13: 56-62.
125. Tonetti MS, D'Aiuto F, Nibali L et al (2007). Treatment of periodontitis and endothelial function. N Engl J Med 356: 911-920.
126. Tuomainen AM, Jauhiainen M, Kovanen PT, Metso J, Paju S, Pussinen PJ (2008). Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathog 44: 111-117.
127. Tuominen R, Reunanen A, Paunio M, Paunio I, Aromaa A (2003). Oral health indicators poorly predict coronary heart disease deaths. J Dent Res 82: 713-718.
128. Ushida Y, Koshy G, Kawashima Y et al (2008). Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement. J Clin Periodontol 35: 969-975.
129. Vidal F, Figueredo CM, Cordovil I, Fischer RG (2009). Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80: 786-791.
130. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT (2000). Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 151: 273-282.
131. Yoshii S, Tsuboi S, Morita I et al (2009). Temporal association of elevated C-reactive protein and periodontal disease in men. J Periodontol 80: 734-739.
132. Yumoto H, Chou HH, Takahashi Y, Davey M, Gibson FC III, Genco CA (2005). Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun 73: 8050-8059.
133. Yumoto H, Yamada M, Shinohara C et al (2007). Soluble products from Eikenella corrodens induce cell proliferation and expression of interleukin-8 and adhesion molecules in endothelial cells via mitogen-activated protein kinase pathways. Oral Microbiol Immunol 22: 36-45.
134. Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto M (2010). Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol 59: 143-51.
135. Zhu J, Quyyumi AA, Norman JE et al (2000). Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 85: 140-146.
136. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE (2001). Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103: 45-51.